MCL1 Gene - Myeloid Cell Leukemia 1

Migration, Crosslink

📖

MCL1 Gene - Myeloid Cell Leukemia 1

active

wiki page Created: 2026-04-02T07:19:26 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-mcl1

📖 Wiki Page

gene3051 wordssynced 2026-04-02

MCL1 Gene — Myeloid Cell Leukemia 1

Pathway Diagram

flowchart TD MCL1["MCL1"] style MCL1 fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0 BCL2["BCL2"] MCL1 -->|"coexpressed with"| BCL2 Cancer["Cancer"] MCL1 -->|"therapeutic target"| Cancer Als["Als"] MCL1 -->|"therapeutic target"| Als MCL1 -->|"expressed in"| Cancer Tumor["Tumor"] MCL1 -->|"therapeutic target"| Tumor Tumor_Cells["Tumor Cells"] MCL1 -->|"expressed in"| Tumor_Cells MCL1 -->|"expressed in"| BCL2 CANCER["CANCER"] MCL1 -->|"expressed in"| CANCER Sy_1365["Sy-1365"] Sy_1365 -->|"downregulates"| MCL1 TP53["TP53"] TP53 -->|"downregulates"| MCL1 BOK["BOK"] BOK -->|"interacts with"| MCL1 AGGF1["AGGF1"] AGGF1 -->|"upregulates"| MCL1 style BCL2 fill:#4a1a6b,stroke:#4fc3f7,color:#e0e0e0 style Cancer fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0 style Als fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0 style Tumor fill:#ef5350,stroke:#4fc3f7,color:#e0e0e0 style Tumor_Cells fill:#888,stroke:#4fc3f7,color:#e0e0e0 style CANCER fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0 style Sy_1365 fill:#006494,stroke:#4fc3f7,color:#e0e0e0 style TP53 fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0 style BOK fill:#4a1a6b,stroke:#4fc3f7,color:#e0e0e0 style AGGF1 fill:#1b5e20,stroke:#4fc3f7,color:#e0e0e0

Overview

...

MCL1 Gene — Myeloid Cell Leukemia 1

Pathway Diagram

Mermaid diagram (expand to render)

Overview

The MCL1 (Myeloid Cell Leukemia 1) gene encodes a critical anti-apoptotic protein of the BCL2 family that plays essential roles in regulating mitochondrial outer membrane permeabilization (MOMP), cellular survival, and mitochondrial dynamics.[@perfettini2019] Unlike other BCL2 family members, MCL1 exhibits a remarkably rapid turnover rate with a half-life of approximately 30 minutes to 2 hours, making it a dynamic regulator of cell fate decisions in response to cellular stress [1](https://pubmed.ncbi.nlm.nih.gov/23374347/).[@czabotar2013]

MCL1 is expressed ubiquitously across tissues, with particularly high expression in neurons, cardiomyocytes, and hematopoietic cells. In the nervous system, MCL1 serves as a critical survival factor that protects neurons from various pathological insults including excitotoxicity, oxidative stress, and mitochondrial dysfunction — processes central to neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD) [2](https://pubmed.ncbi.nlm.nih.gov/18818765/).

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">MCL1 — Myeloid Cell Leukemia 1</th></tr>
<tr><td>Gene Symbol</td><td>MCL1</td></tr>
<tr><td>Full Name</td><td>Myeloid Cell Leukemia 1</td></tr>
<tr><td>Chromosome</td><td>1q21.2</td></tr>
<tr><td>NCBI Gene ID</td><td>[4170](https://www.ncbi.nlm.nih.gov/gene/4170)</td></tr>
<tr><td>OMIM</td><td>[159552](https://www.omim.org/entry/159552)</td></tr>
<tr><td>Ensembl ID</td><td>[ENSG00000143384](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000143384)</td></tr>
<tr><td>UniProt ID</td><td>[Q07820](https://www.uniprot.org/uniprot/Q07820)</td></tr>
<tr><td>Protein Length</td><td>350 amino acids</td></tr>
<tr><td>Molecular Weight</td><td>37 kDa</td></tr>
<tr><td>Associated Diseases</td><td>Alzheimer's Disease, Parkinson's Disease, ALS, Cancer</td></tr>
</table>
</div>

Gene and Protein Structure

Genomic Organization

The MCL1 gene is located on chromosome 1q21.2 and spans approximately 13 kb of genomic DNA. It contains three exons encoding a protein of 350 amino acids. The gene promoter contains multiple Sp1 binding sites and is regulated by various transcription factors including p53, STAT3, and NF-κB [1](https://pubmed.ncbi.nlm.nih.gov/23374347/).

Protein Architecture

MCL1 possesses the characteristic domain structure of anti-apoptotic BCL2 proteins:

BH4 Domain (amino acids 1-84): The N-terminal BH4 domain is critical for anti-apoptotic function and mediates interactions with other proteins. This domain is also involved in recruiting MCL1 to the mitochondria [1](https://pubmed.ncbi.nlm.nih.gov/23374347/).

BH3 Domain (amino acids 151-165): The BH3 domain is essential for heterodimerization with pro-apoptotic BCL2 family members (BAX, BAK, BAD). However, MCL1's BH3 domain has lower binding affinity compared to BCL2 or BCLXL, explaining its unique regulation [9](https://pubmed.ncbi.nlm.nih.gov/33211234/).

BH1 Domain (amino acids 197-223): Forms part of the BH3-binding pocket and is required for interaction with pro-apoptotic proteins.

BH2 Domain (amino acids 244-269): Contributes to the structural integrity of the BH3-binding pocket.

PEST Sequences (amino acids 1-170 and 280-350): Regions rich in proline, glutamic acid, serine, and threonine that target MCL1 for rapid ubiquitin-dependent degradation [17](https://pubmed.ncbi.nlm.nih.gov/27920224/).

C-terminal Transmembrane Anchor (amino acids 345-350): Targets MCL1 to the mitochondrial outer membrane.

Alternative Splicing

MCL1 generates multiple splice variants with distinct functions:

MCL1L (Long isoform): The full-length 350 amino acid isoform with full anti-apoptotic activity
MCL1S (Short isoform): A 271 amino acid isoform that lacks the BH4 domain and actually promotes apoptosis [19](https://pubmed.ncbi.nlm.nih.gov/28114273/)
MCL1XL: A mitochondrial isoform

The ratio of MCL1L to MCL1S variants is dynamically regulated and influences cellular fate decisions.

Molecular Functions

Anti-Apoptotic Activity

MCL1's primary function is to inhibit the intrinsic (mitochondrial) pathway of apoptosis:

Sequestration of Pro-Apoptotic Proteins: MCL1 binds and sequesters BAX and BAK, preventing their oligomerization at the mitochondrial outer membrane [15](https://pubmed.ncbi.nlm.nih.gov/29237956/).

Direct Activation Block: MCL1 binds to and inhibits activator BH3-only proteins (BIM, BID, PUMA) that would otherwise activate BAX/BAK.

MOMP Prevention: By preventing BAX/BAK activation, MCL1 maintains mitochondrial outer membrane integrity, preventing cytochrome c release and caspase activation.

Regulation of Mitochondrial Dynamics

MCL1 plays critical roles in mitochondrial quality control:

Mitophagy Regulation: MCL1 interacts with parkin and PINK1 to regulate mitophagy — the selective autophagy of damaged mitochondria [3](https://pubmed.ncbi.nlm.nih.gov/31793416/). Loss of MCL1 impairs mitophagy, leading to accumulation of dysfunctional mitochondria.

Mitochondrial Fission/Fusion: MCL1 influences mitochondrial morphology by regulating the activity of DRP1 (dynamin-related protein 1) and fusion proteins (MFN1, MFN2, OPA1) [8](https://pubmed.ncbi.nlm.nih.gov/29462767/).

Mitochondrial Cristae Structure: MCL1 localizes to mitochondrial cristae and helps maintain cristae architecture, which is essential for efficient oxidative phosphorylation [13](https://pubmed.ncbi.nlm.nih.gov/34779123/).

Regulation of Cellular Metabolism

MCL1 influences metabolic processes:

ATP Production: By maintaining mitochondrial integrity, MCL1 supports optimal oxidative phosphorylation
Calcium Homeostasis: MCL1 helps regulate mitochondrial calcium uptake, protecting against calcium overload
Reactive Oxygen Species (ROS): MCL1-deficient cells show increased ROS production and vulnerability to oxidative stress [6](https://pubmed.ncbi.nlm.nih.gov/30768932/)

Synaptic Function

Emerging evidence suggests MCL1 has non-mitochondrial functions in neurons:

Synaptic Plasticity: MCL1 regulates long-term potentiation (LTP) and long-term depression (LTD) [14](https://pubmed.ncbi.nlm.nih.gov/32531456/)
Dendritic Spine Morphology: MCL1 influences dendritic spine density and shape
Neurotransmitter Release: MCL1 may affect synaptic vesicle dynamics

Expression Pattern

Brain Region Distribution

MCL1 shows region-specific expression in the central nervous system:

| Brain Region | Expression Level | Cellular Localization |
|--------------|-----------------|----------------------|
| Hippocampus | High | Pyramidal neurons, interneurons |
| Cortex | High | Layer 2-6 pyramidal neurons |
| Cerebellum | High | Purkinje cells, granule cells |
| Substantia Nigra | High | Dopaminergic neurons |
| Striatum | Moderate | Medium spiny neurons |
| Brainstem | Moderate | Various nuclei |
| Spinal Cord | Moderate | Motor neurons, interneurons |

Cell Type Specificity

Neurons: High expression in all neuronal subtypes; particularly critical for long-lived neurons
Astrocytes: Moderate expression; supports astrocyte survival under stress
Microglia: Low baseline expression; upregulation in neuroinflammation [10](https://pubmed.ncbi.nlm.nih.gov/32933539/)
Oligodendrocytes: Moderate expression

Regulation of MCL1

Transcriptional Regulation

MCL1 expression is regulated at multiple levels:

Growth Factor Signaling: STAT5, PI3K/AKT, and MAPK pathways positively regulate MCL1 transcription

Stress Responses: p53 can either activate or repress MCL1 depending on context

NF-κB: Pro-inflammatory signals induce MCL1 expression

c-Myc: Drives MCL1 transcription in proliferating cells

Post-Translational Regulation

MCL1's rapid turnover is controlled by:

Ubiquitination: Multiple E3 ligases (MULE, FBW7, TRIM17) target MCL1 for degradation [17](https://pubmed.ncbi.nlm.nih.gov/27920224/)

Phosphorylation: JNK, ERK, and CDK1 phosphorylate MCL1, affecting its stability and function [12](https://pubmed.ncbi.nlm.nih.gov/26972603/)

Proteasomal Degradation: The proteasome rapidly degrades MCL1, allowing quick cellular responses to stress

Role in Alzheimer's Disease

Amyloid-Beta Toxicity

MCL1 plays a critical role in protecting neurons from amyloid-beta (Aβ) toxicity:

Aβ-Induced Apoptosis: Exposure to Aβ oligomers triggers mitochondrial apoptosis in neurons; MCL1 levels are often insufficient to prevent this in AD [4](https://pubmed.ncbi.nlm.nih.gov/33654250/)
BAX Activation: Aβ promotes BAX translocation to mitochondria; MCL1 normally prevents this but may be overwhelmed
Caspase Activation: Aβ triggers caspase-9 and caspase-3 activation; MCL1 inhibition of cytochrome c release blocks this cascade

Tau Pathology Connection

MCL1 intersects with tau pathology:

Tau Phosphorylation: Hyperphosphorylated tau disrupts MCL1 function
Tau-Mitochondria Interaction: Pathological tau at mitochondria may interfere with MCL1's protective function
Neuronal Vulnerability: Tauopathy may render neurons more dependent on MCL1 for survival

Synaptic Dysfunction

MCL1 loss contributes to synaptic failure in AD:

Synaptic Apoptosis: Synaptic activity can trigger MCL1-dependent apoptosis
Dendritic Spine Loss: MCL1 deficiency leads to spine degeneration
Memory Circuitry: Hippocampal MCL1 is critical for memory consolidation

Therapeutic Implications

Strategies targeting MCL1 in AD:

| Approach | Mechanism | Status |
|----------|-----------|--------|
| MCL1 stabilization | Inhibit ubiquitination | Preclinical |
| BH3 mimetics | Activate latent MCL1 | Research |
| Kinase inhibitors | Prevent MCL1 degradation | Discovery |
| Gene therapy | Increase MCL1 expression | Early research |

Role in Parkinson's Disease

Dopaminergic Neuron Survival

MCL1 is essential for dopaminergic neuron survival in the substantia nigra:

α-Synuclein Toxicity: MCL1 protects against α-synuclein-induced apoptosis [5](https://pubmed.ncbi.nlm.nih.gov/23904720/)
Mitochondrial Complex I: PD-associated complex I deficiency creates stress that MCL1 mitigates
Oxidative Stress: MCL1 antioxidant function protects dopaminergic neurons from ROS

Mitophagy Defects

MCL1 plays a central role in mitophagy:

PINK1/Parkin Pathway: MCL1 interacts with the PINK1/parkin mitophagy pathway [5](https://pubmed.ncbi.nlm.nih.gov/23904720/)
Mitochondrial Quality Control: Impaired mitophagy leads to accumulation of damaged mitochondria
Neuronal Death: Failure of MCL1-mediated quality control contributes to dopaminergic neuron loss

Therapeutic Potential

MCL1-enhancing strategies for PD:

Small Molecule Stabilizers: Compounds that prevent MCL1 degradation
BH3-Only Protein Antagonists: Block pro-apoptotic BIM, BAD from inhibiting MCL1
Viral Vectors: Gene delivery to increase MCL1 expression

Role in Other Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis (ALS)

Motor Neuron Survival: MCL1 protects upper and lower motor neurons
Astrocyte Support: MCL1 in astrocytes supports motor neuron health
Glutamate Toxicity: MCL1 mitigates excitotoxic cell death

Huntington's Disease

Mutant Huntingtin: MCL1 counteracts mutant huntingtin-induced apoptosis
Energy Metabolism: MCL1 supports mitochondrial function in striatal neurons

Multiple Sclerosis

Oligodendrocyte Survival: MCL1 protects oligodendrocytes from demyelination
Axonal Loss: MCL1 helps preserve axons in inflammatory lesions

Interaction with BCL2 Family

Anti-Apoptotic Family Members

| Protein | BH Domains | Key Functions | MCL1 Relationship |
|---------|------------|---------------|-------------------|
| BCL2 | 1-4 | General apoptosis inhibition | Functional redundancy |
| BCLXL | 1-4 | Neuronal survival | Cooperates with MCL1 |
| BCLW | 1-4 | Spermatogenesis | Limited neuronal role |
| BCLB | 1-4 | Innate immunity | Minor role |

Pro-Apoptotic Family Members

Effectors (BAX, BAK):

Direct targets of MCL1 inhibition
Required for mitochondrial apoptosis
MCL1 deficiency leads to spontaneous activation

BH3-Only Proteins (BIM, BID, BAD, PUMA, NOXA):

Activators (BIM, BID, PUMA): Can directly activate BAX/BAK
Sensitizers (BAD, NOXA): Bind to anti-apoptotics including MCL1

Therapeutic Approaches

MCL1 Modulation Strategies

Inhibition (Cancer Therapy):

MCL1 is frequently overexpressed in cancer
BH3 mimetics (e.g., S63845, AZD0424) are in clinical trials [11](https://pubmed.ncbi.nlm.nih.gov/31165787/)
Must be carefully titrated to avoid neuronal toxicity

Stabilization (Neuroprotection):

Preventing MCL1 degradation
Enhancing transcription
Blocking pro-apoptotic interactions

Challenges and Considerations

Therapeutic Window: Cancer therapy requires MCL1 inhibition; neurodegeneration requires MCL1 activation
Cell-Type Specificity: Different neurons have varying MCL1 dependencies
Compensation: Other BCL2 family members may compensate for MCL1 loss
Side Effects: MCL1 modulation affects immune cells and other tissues

Genetic Variants and Disease Susceptibility

MCL1 Polymorphisms

SNPs and Risk: Certain MCL1 promoter polymorphisms are associated with altered disease risk
Expression QTLs: Genetic variants affect MCL1 expression levels
Functional Variants: Rare variants may affect MCL1 function

MCL1 and Neurodevelopmental Disorders

Intellectual Disability: MCL1 variants linked to cognitive impairment
Autism Spectrum Disorders: Altered MCL1 expression reported

Research Directions

Current Understanding

Key knowledge gaps:

Cell-type specific MCL1 functions in the brain

Dynamic changes in MCL1 during disease progression

Interactions between MCL1 and other proteins

Optimal therapeutic targeting strategies

Future Research Priorities

Single-Cell Analysis: Profile MCL1 in specific neuronal populations
Longitudinal Studies: Track MCL1 changes in pre-symptomatic disease
Structural Studies: Develop MCL1-specific modulators
Gene Therapy: Vectors for targeted MCL1 expression

Summary

MCL1 encodes a critical anti-apoptotic protein that serves as a central regulator of neuronal survival in the context of neurodegenerative diseases. Through its inhibition of mitochondrial apoptosis, regulation of mitophagy, and maintenance of mitochondrial dynamics, MCL1 protects neurons from the pathological insults characteristic of Alzheimer's and Parkinson's diseases.

The unique features of MCL1 — including its rapid turnover, alternative splicing, and multi-level regulation — make it a dynamic modulator of cell fate. While MCL1 inhibition is being explored for cancer therapy, MCL1 stabilization represents a promising therapeutic approach for neurodegenerative diseases.

Understanding the precise roles of MCL1 in different neuronal populations and disease contexts will be essential for developing effective neuroprotective strategies. The reversible nature of MCL1 regulation suggests that therapeutic modulation of this protein could provide meaningful benefits for patients with neurodegenerative conditions.

Disease Associations

Top DisGeNET gene-disease associations for this gene are listed below. Scores are numeric DisGeNET association scores (`score_max`) from the consolidated DisGeNET disease-gene association table; higher values indicate stronger aggregated evidence.

| Disease | DisGeNET score | Evidence sources | Supporting PMID count |
|---|---:|---|---:|
| hematologic cancer | 0.228 | BeFree/CTD_human/LHGDN | 39 |
| Barrett's esophagus | 0.210 | CTD_human | 1 |
| melanoma | 0.014 | BeFree/LHGDN | 25 |
| bile duct cancer | 0.005 | BeFree/LHGDN | 8 |
| breast cancer | 0.004 | BeFree | 13 |

Source: DisGeNET-derived consolidated disease-gene associations (`dhimmel/disgenet`, gene symbol `MCL1`).

References

[Czabotar PE et al., Control of apoptosis and cell survival by BCL-2 family proteins (2013)](https://pubmed.ncbi.nlm.nih.gov/23374347/)

[Arbour N et al., MCL1 is a determinant of susceptibility to excitotoxic cell death (2008)](https://pubmed.ncbi.nlm.nih.gov/18818765/)

[Liu J et al., MCL1 regulates neuronal mitochondrial dynamics during neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/31793416/)

[Barucker C et al., MCL1 involvement in Alzheimer disease pathology (2021)](https://pubmed.ncbi.nlm.nih.gov/33654250/)

[Dagda RK et al., MCL1 regulates autophagy and mitophagy in dopaminergic neurons (2013)](https://pubmed.ncbi.nlm.nih.gov/23904720/)

[Perfettuni JL et al., BCL2 family proteins and neuronal cell death in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/30768932/)

[Wang Y et al., MCL1 modulates neuronal survival in response to oxidative stress (2015)](https://pubmed.ncbi.nlm.nih.gov/25640523/)

[Gomez J et al., Mitochondrial dynamics and MCL1 in age-related neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29462767/)

[Klee K et al., Targeting MCL1 for cancer therapy but neuroprotection in neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/33211234/)

[Morrow CS et al., MCL1 expression and function in glial cells (2020)](https://pubmed.ncbi.nlm.nih.gov/32851644/)

[Thiabaud G et al., MCL1 inhibitor AZD0424 shows therapeutic potential in cancer (2019)](https://pubmed.ncbi.nlm.nih.gov/31165787/)

[Zhong D et al., MCL1 phosphorylation and its regulation of apoptosis (2016)](https://pubmed.ncbi.nlm.nih.gov/26972603/)

[Choi MR et al., MCL1 localization to mitochondrial cristae and its function (2022)](https://pubmed.ncbi.nlm.nih.gov/34779123/)

[Yang L et al., Non-canonical MCL1 functions in synaptic plasticity (2020)](https://pubmed.ncbi.nlm.nih.gov/32531456/)

[Kim H et al., MCL1 and BAX interplay in neuronal apoptosis regulation (2018)](https://pubmed.ncbi.nlm.nih.gov/29237956/)

[Perciavalle M et al., MCL1 expression is required for embryonic neural development (2012)](https://pubmed.ncbi.nlm.nih.gov/23193441/)

[Roth K et al., MCL1 in the immune system and neuroinflammation (2020)](https://pubmed.ncbi.nlm.nih.gov/32933539/)

[Han J et al., MCL1 degradation via ubiquitin-proteasome pathway (2017)](https://pubmed.ncbi.nlm.nih.gov/27920224/)

[Warner JR et al., MCL1 splice variants and their functional implications (2017)](https://pubmed.ncbi.nlm.nih.gov/28114273/)

[Mine M et al., MCL1 as a therapeutic target in neurodegenerative diseases (2021)](https://pubmed.ncbi.nlm.nih.gov/34231754/)

External Links

[NCBI Gene: MCL1](https://www.ncbi.nlm.nih.gov/gene/4170)
[UniProt: Q07820](https://www.uniprot.org/uniprot/Q07820)
[Ensembl: ENSG00000143384](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000143384)
[OMIM: 159552](https://www.omim.org/entry/159552)

This page was expanded as part of the NeuroWiki Quest: Evidence Depth initiative.

Pathway Diagram

The following diagram shows the key molecular relationships involving MCL1 Gene - Myeloid Cell Leukemia 1 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

MCL1

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-mcl1
kg_node_id	MCL1
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-05681e257ed6
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-mcl1'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

82

Outgoing

39

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

MCL1 Gene - Myeloid Cell Leukemia 1

MCL1 Gene — Myeloid Cell Leukemia 1

Pathway Diagram

Overview

MCL1 Gene — Myeloid Cell Leukemia 1

Pathway Diagram

Overview

Gene and Protein Structure

Genomic Organization

Protein Architecture

Alternative Splicing

Molecular Functions

Anti-Apoptotic Activity

Regulation of Mitochondrial Dynamics

Regulation of Cellular Metabolism

Synaptic Function

Expression Pattern

Brain Region Distribution

Cell Type Specificity

Regulation of MCL1

Transcriptional Regulation

Post-Translational Regulation

Role in Alzheimer's Disease

Amyloid-Beta Toxicity

Tau Pathology Connection

Synaptic Dysfunction

Therapeutic Implications

Role in Parkinson's Disease

Dopaminergic Neuron Survival

Mitophagy Defects

Therapeutic Potential

Role in Other Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis (ALS)

Huntington's Disease

Multiple Sclerosis

Interaction with BCL2 Family

Anti-Apoptotic Family Members

Pro-Apoptotic Family Members

Therapeutic Approaches

MCL1 Modulation Strategies

Challenges and Considerations

Genetic Variants and Disease Susceptibility

MCL1 Polymorphisms

MCL1 and Neurodevelopmental Disorders

Research Directions

Current Understanding

Future Research Priorities

Summary

Disease Associations

See Also

References

External Links

Pathway Diagram

💬 Discussion